Galectin Therapeutics Inc PHPN-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 06/11/21 CEST
3.10quote price arrow down-0.08 (-2.52%)
52 week range
1.57 - 4.66

...

Loading . . .
  • Open3.06
  • Day High3.10
  • Day Low3.06
  • Prev Close3.18
  • 52 Week High4.66
  • 52 Week High Date04/29/21
  • 52 Week Low1.57
  • 52 Week Low Date02/01/21

Key Stats

  • Market Cap214.45M
  • Shares Out57.19M
  • 10 Day Average Volume58.67
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change70.33

KEY STATS

  • Open3.06
  • Day High3.10
  • Day Low3.06
  • Prev Close3.18
  • 52 Week High4.66
  • 52 Week High Date04/29/21
  • 52 Week Low1.57
  • 52 Week Low Date02/01/21
  • Market Cap214.45M
  • Shares Out57.19M
  • 10 Day Average Volume58.67
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change70.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.39
  • P/E (TTM)-7.95
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galectin Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally occurring, readily-available plant materials as starting material in manufacturing processes to create complex carbohydrates with specific molecular...
Richard Uihlein
Non-Executive Chairman
Joel Lewis CPA
President
Jack Callicutt CPA
Chief Financial Officer
Eliezer Zomer Ph.D.
Executive Vice President
J. Rex Horton
Vice President
Address
4960 Peachtree Industrial Blvd Ste 240
Berkeley Lake, GA
30071-1580
United States